承德医学院中药研究所/河北省中药研究与开发重点实验室,河北 承德 067000
Received:17 December 2024,
Revised:2025-04-27,
Accepted:27 April 2025,
Published:15 June 2025
移动端阅览
王梦颜,孙莹,黄思睿,等.两种方法制备的水飞蓟宾纳米晶的在体肠吸收及组织分布研究 [J].中国药房,2025,36(11):1335-1339.
WANG Mengyan,SUN Ying,HUANG Sirui,et al.Study on the in vivo intestinal absorption and tissue distribution of silybin nanocrystals prepared by two methods[J].ZHONGGUO YAOFANG,2025,36(11):1335-1339.
王梦颜,孙莹,黄思睿,等.两种方法制备的水飞蓟宾纳米晶的在体肠吸收及组织分布研究 [J].中国药房,2025,36(11):1335-1339. DOI: 10.6039/j.issn.1001-0408.2025.11.08.
WANG Mengyan,SUN Ying,HUANG Sirui,et al.Study on the in vivo intestinal absorption and tissue distribution of silybin nanocrystals prepared by two methods[J].ZHONGGUO YAOFANG,2025,36(11):1335-1339. DOI: 10.6039/j.issn.1001-0408.2025.11.08.
目的
2
研究两种方法制备的水飞蓟宾(Sy)纳米晶在大鼠各肠段的吸收特征和组织分布差异。
方法
2
采用高压均质法和反溶剂沉淀法制备粒径相当的Sy纳米晶(即Sy-NS-G、Sy-NS-F)。将大鼠随机分为Sy原料药组、Sy-NS-G组和Sy-NS-F组,每组均设置低、中、高(60、120、180 μg/mL)3个质量浓度(以Sy计),每组3只;根据在体单向肠灌流实验,考察Sy原料药、Sy-NS-G和Sy-NS-F在大鼠不同肠段(十二指肠、空肠、回肠)的吸收速率常数(
K
a
)和表观吸收系数(
P
app
)。另将大鼠分为Sy原料药组、Sy-NS-G组和Sy-NS-F组,每组20只;各组大鼠单次灌胃剂量均为50 mg/kg(以Sy计),分别于给药后0.3、1、4、10、24 h处死,考察Sy原料药、Sy-NS-G和Sy-NS-F在心、肝、脾、肺、肾、脑和小肠的组织分布情况。
结果
2
Sy-NS-G、Sy-NS-F、Sy原料药在十二指肠、空肠中的
K
a
、P
app
随着Sy质量浓度的增加无明显变化(
P
>0.05),Sy-NS-F在十二指肠的吸收高于Sy-N
S-G,Sy-NS-G和Sy原料药的吸收部位主要在回肠,Sy-NS-F的吸收部位主要在十二指肠和回肠。Sy-NS-G和Sy-NS-F在大鼠不同组织中的分布不同,Sy-NS-G在大部分组织中1 h内达峰,分布浓度由高到低依次为小肠>脾>心>肺>肝≈脑>肾;Sy-NS-F在大部分组织中也是1 h内达峰,分布浓度由高到低依次为小肠>脾>肾>肺>心≈肝>脑。
结论
2
Sy纳米晶在十二指肠、空肠中的吸收方式为被动扩散,且在十二指肠中,Sy-NS-F的吸收大于Sy-NS-G;Sy-NS-G和Sy-NS-F在大鼠体内的组织分布有明显区别。
OBJECTIVE
2
To investigate the absorption characteristics and tissue distribution of silybin (Sy) nanocrystals prepared by two methods in different intestinal segments of rats.
METHODS
2
Sy nanocrystals (i.e. Sy-NS-G and Sy-NS-F) with comparable particle sizes were prepared using high-pressure homogenization and anti-solvent precipitation methods, respectively. Rats were randomly divided into three groups: Sy raw drug group, Sy-NS-G group, and Sy-NS-F group. Each group was further divided into three subgroups with low, medium, and high (60, 120, 180 μg/mL) mass concentrations (calculated based on Sy), with 3 rats in each subgroup. The absorption rate constant (
K
a
) and apparent absorption coefficient (
P
app
) of Sy raw drug, Sy-NS-G and Sy-NS-F in different intestinal segments were investigated by using the
in vivo
one-way intestinal perfusion experiment. Additionally, the rats were divided into three groups: Sy raw drug group, Sy-NS-G group, and Sy-NS-F group, with 20 rats in each group. Rats in each group were administered a single intragastric dose of 50 mg/kg (calculated based on Sy). They were sacrificed at 0.3, 1, 4, 10, and 24 hours post-administration respectively, to investigate the tissue distribution of Sy raw drug, Sy-NS-G, and Sy-NS-F in the heart, liver, spleen, lungs, kidneys, brain and intestines.
RESULTS
2
In duodenum and jejunum, the
K
a
and
P
app
of the nanocrystals prepared by the two methods remained unchanged with the increase
of Sy concentration, and there was no significant difference (
P
>0.05); the absorption of Sy-NS-F in the duodenum was greater than that of Sy-NS-G; the absorption sites of Sy-NS-G and Sy raw drug were mainly in the ileum, while those of Sy-NS-F were mainly in the duodenum and ileum. The concentrations of Sy-NS-G and Sy-NS-F in different tissues of rats were different; Sy-NS-G peaked in most tissues at 1 h, and the distribution concentration was as follows: intestine>spleen>heart>lungs>liver≈brain>kidneys. Sy-NS-F reached its peak at 1 h, and the distribution concentration was in the order of intestine>spleen>kidney>lung>heart≈liver>brain.
CONCLUSIONS
2
The absorption mode of Sy nanocrystals in the duodenum and ileum is mainly passive diffusion. In the duodenum, the absorption of Sy-NS-F is greater than that of Sy-NS-G; there are significant differences in the tissue distribution of Sy-NS-G and Sy-NS-F in rats.
陈江丽 , 邱智东 , 金媛媛 , 等 . 水飞蓟素脂质体的制备、质量评价及其对HaCaT细胞增殖和摄取的影响 [J ] . 中草药 , 2022 , 53 ( 12 ): 3614 - 3624 .
袁义美 , 崔宁 , 张兰 . 异甘草酸镁联合水飞蓟宾对酒精性肝硬化患者肝功能及肝纤维化指标的影响 [J ] . 医学理论与实践 , 2024 , 37 ( 1 ): 57 - 59 .
郭声 , 刘长虹 , 刘颖 , 等 . 水飞蓟宾治疗慢性乙型病毒性肝炎临床研究 [J ] . 光明中医 , 2023 , 38 ( 24 ): 4736 - 4739 .
DEHGHAN A , GHANBARZADEH S , GHIASS M , et al . Silibinin solubilization:combined effect of co-solvency and inclusion complex formation [J ] . Drug Dev Ind Pharm , 2024 , 50 ( 5 ): 470 - 480 .
任淑珍 . 水飞蓟宾过饱和纳米自微乳研制与评价 [D ] . 上海 : 上海中医药大学 , 2019 .
AGHEMO A , ALEKSEEVA O P , ANGELICO F , et al . Role of silymarin as antioxidant in clinical management of chronic liver diseases:a narrative review [J ] . Ann Med , 2022 , 54 ( 1 ): 1548 - 1560 .
张领 . 两种制备方法对水飞蓟宾纳米混悬剂体内外行为的影响 [D ] . 承德 : 承德医学院 , 2022 .
陈龙 , 王瑞锋 , 张振凯 , 等 . 基于药动学-药效学的中药引经理论现代研究进展与思考 [J ] . 中成药 , 2025 , 47 ( 1 ): 133 - 138 .
国家药典委员会 . 中华人民共和国药典:三部 [M ] . 2020年版 . 北京 : 中国医药科技出版社 , 2020 : 682 .
余文静 , 黄群 , 陈丹 , 等 . 三叶青地上部分抗炎提取物固体纳米晶肠吸收动力学研究 [J ] . 药物分析杂志 , 2023 , 43 ( 2 ): 262 - 279 .
国家药典委员会 . 中华人民共和国药典:四部 [M ] . 2020年版 . 北京 : 中国医药科技出版社 , 2020 : 466 .
王镜 . 银杏内酯B纳米混悬液的制备、体内外评价及固化研究 [D ] . 成都 : 成都中医药大学 , 2021 .
孙慧园 , 陈浩 , 梅朝叶 , 等 . 白及醇提物中5种主要活性成分的在体肠吸收特征研究 [J ] . 中国药房 , 2019 , 30 ( 6 ): 757 - 764 .
XU F X , YANG J , NEGISHI H , et al . Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats [J ] . Food Funct , 2018 , 9 ( 9 ): 4926 - 4935 .
0
Views
24
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
